Icecure Medical Ltd [NASDAQ: ICCM] jumped around 0.2 points on Thursday, while shares priced at $1.19 at the close of the session, up 20.80%.
Icecure Medical Ltd stock is now 75.77% up from its year-to-date (YTD) trading value. ICCM Stock saw the intraday high of $1.31 and lowest of $1.15 per share. The company’s 52-week high price is 1.63, which means current price is +70.00% above from all time high which was touched on 02/19/25.
Compared to the average trading volume of 1.19M shares, ICCM reached a trading volume of 17131125 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Icecure Medical Ltd [ICCM]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ICCM shares is $2.59 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ICCM stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 24.16, with the Price to Cash per share for the same quarter was set at 0.08.
How has ICCM stock performed recently?
Icecure Medical Ltd [ICCM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 35.91. With this latest performance, ICCM shares gained by 14.42% in over the last four-week period, additionally sinking by -13.99% over the last 6 months – not to mention a rise of 10.25% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ICCM stock in for the last two-week period is set at 71.85, with the RSI for the last a single of trading hit 0.0979, and the three-weeks RSI is set at 0.0812 for Icecure Medical Ltd [ICCM]. The present Moving Average for the last 50 days of trading for this stock 0.9730, while it was recorded at 1.0088 for the last single week of trading, and 1.0813 for the last 200 days.
Icecure Medical Ltd [ICCM]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Icecure Medical Ltd [ICCM] shares currently have an operating margin of -569.07% and a Gross Margin at 35.92%. Icecure Medical Ltd’s Net Margin is presently recorded at -559.02%.
Icecure Medical Ltd (ICCM) Capital Structure & Debt Analysis
According to recent financial data for Icecure Medical Ltd. ( ICCM), the Return on Equity (ROE) stands at -230.80%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -120.09%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Icecure Medical Ltd’s Return on Invested Capital (ROIC) is -528.14%, showcasing its effectiveness in deploying capital for earnings.
Icecure Medical Ltd (ICCM) Efficiency & Liquidity Metrics
Based on Icecure Medical Ltd’s (ICCM) latest financial statements, the Debt-to-Equity Ratio is 0.82%, indicating its reliance on debt financing relative to shareholder equity.
Icecure Medical Ltd (ICCM) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Icecure Medical Ltd. (ICCM) effectively leverages its workforce, generating an average of -$216388.89 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.18% and a Quick Ratio of 0.88%, indicating strong ability to cover short-term liabilities.
Earnings analysis for Icecure Medical Ltd [ICCM]
With the latest financial reports released by the company, Icecure Medical Ltd posted -0.08/share EPS, while the average EPS was predicted by analysts to be reported at -0.08/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ICCM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Icecure Medical Ltd go to 31.41%.
Insider trade positions for Icecure Medical Ltd [ICCM]
There are presently around $0.36%, or 0.61%% of ICCM stock, in the hands of institutional investors. The top three institutional holders of ICCM stocks are: CITADEL ADVISORS LLC with ownership of 0.17 million shares, which is approximately 0.3627%. RENAISSANCE TECHNOLOGIES LLC, holding 66400.0 shares of the stock with an approximate value of $$49136.0 in ICCM stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $$20000.0 in ICCM stock with ownership which is approximately 0.0582%.
